It has been suggested that a sustained rise in resting levels of cytosolic calcium [Ca2+]i of pancreatic islets is responsible for impaired insulin secretion in chronic renal failure (CRF). Evidence for such an event is lacking and the mechanisms through which it may affect insulin secretion are not known. Studies were conducted in normal, CRF, and normocalcemic, parathyroidectomized (PTX) CRF rats to answer these questions. Resting levels of [Ca2+]i of islets from CRF rats were higher (P less than 0.01) than in control of CRF-PTX rats. [3H]2-deoxyglucose uptake and cAMP production by islets were not different in the three groups. Insulin content of, and glucose-induced insulin secretion by islets from CRF rats was lower (P less than 0.01) than in control and CRF-PTX rats. In contrast, glyceraldehyde-induced insulin release by CRF islets was normal. Basal ATP content, both glucose-stimulated ATP content and ATP/ADP ratio, net lactic acid output, Vmax of phosphofructokinase-1, and Ca2+ ATPase of islets from CRF rats were lower (P less than 0.02-less than 0.01) than in normal or CRF-PTX animals. Data show that: (a) Glucose but not glyceraldehyde-induced insulin secretion is impaired in CRF; (b) the impairment in glucose-induced insulin release in CRF is due to a defect in the metabolism of glucose; (c) this latter defect is due to reduced ATP content induced partly by high [Ca2+]i of islets; and (d) the high [Ca2+]i in islets of CRF rats is due to augmented PTH-induced calcium entry into cells and decreased calcium extrusion from the islets secondary to reduced activity of the Ca2+ ATPase.
G Z Fadda, S M Hajjar, A F Perna, X J Zhou, L G Lipson, S G Massry
Title and authors | Publication | Year |
---|---|---|
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease.
Rhee CM, Kalantar-Zadeh K, Tuttle KR |
Current Opinion in Nephrology and Hypertension | 2022 |
Extracellular Inorganic Phosphate-Induced Release of Reactive Oxygen Species: Roles in Physiological Processes and Disease Development
MA Lacerda-Abreu, JR Meyer-Fernandes |
International journal of molecular sciences | 2021 |
When ESKD complicates the management of diabetes mellitus
JH William, A Morales, SE Rosas |
Seminars in Dialysis | 2020 |
Disturbances in Insulin–Glucose Metabolism in Patients With Advanced Renal Disease With and Without Diabetes
MN Rahhal, NE Gharaibeh, L Rahimi, F Ismail-Beigi |
The Journal of clinical endocrinology and metabolism | 2019 |
Vascular toxicity of urea, a new “old player” in the pathogenesis of chronic renal failure induced cardiovascular diseases
I Giardino, M DApolito, M Brownlee, AB Maffione, AL Colia, M Sacco, P Ferrara, M Pettoello-Mantovani |
TURK PEDIATR ARSIVI | 2018 |
Metabolic Abnormalities in Diabetes and Kidney Disease: Role of Uremic Toxins
L Koppe, D Fouque, CO Soulage |
Current Diabetes Reports | 2018 |
Higher blood urea nitrogen is associated with increased risk of incident diabetes mellitus
Y Xie, B Bowe, T Li, H Xian, Y Yan, Z Al-Aly |
Kidney International | 2017 |
Urea impairs β-cell glycolysis and insulin secretion in chronic kidney disease
Laetitia Koppe, Elsa Nyam, Kevin Vivot, Jocelyn Manning Fox, Xiao-Qing Dai, Bich Nguyen, Dominique Trudel, Attané Camille, Valentine Moullé, Patrick MacDonald, Julien Ghislain, Vincent Poitout |
Journal of Clinical Investigation | 2016 |
Intracellular calcium increases in vascular smooth muscle cells with progression of chronic kidney disease in a rat model
SD Rodenbeck, CA Zarse, ML McKenney-Drake, RS Bruning, M Sturek, NX Chen, SM Moe |
Nephrology Dialysis Transplantation | 2016 |
Update on Glycemic Control for the Treatment of Diabetic Kidney Disease
GN Nadkarni, R Yacoub, SG Coca |
Current Diabetes Reports | 2015 |
Mitochondrial oxidative stress mediates high-phosphate-induced secretory defects and apoptosis in insulin-secreting cells
TT Nguyen, X Quan, KH Hwang, S Xu, R Das, SK Choi, A Wiederkehr, CB Wollheim, SK Cha, KS Park |
American journal of physiology. Endocrinology and metabolism | 2015 |
Nutritional Management of Renal Disease
A Molfino, BR Don, GA Kaysen |
Nutritional Management of Renal Disease | 2013 |
Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease
A Lishmanov, S Dorairajan, Y Pak, K Chaudhary, A Chockalingam |
International Urology and Nephrology | 2011 |
Association of insulin resistance with arterial stiffness in nondiabetic peritoneal dialysis patients
E Tatar, MS Demirci, F Kircelli, O Gungor, MN Turan, ES Ok, G Asci, M Ozkahya, E Ok |
International Urology and Nephrology | 2011 |
Sequence of Cellular Events in Pancreatic Islets Leading to Impaired Insulin Secretion in Chronic Kidney Disease
SG Massry |
Journal of Renal Nutrition | 2011 |
Predicting hospital cost in CKD patients through blood chemistry values
RW Bessette, RL Carter |
BMC Nephrology | 2011 |
Long-term treatment with atrial natriuretic peptide inhibits ATP production and insulin secretion in rat pancreatic islets
H You, SG Laychock |
American journal of physiology. Endocrinology and metabolism | 2011 |
ACTIVATION OF CASPASE-3 IN THE SKELETAL MUSCLE DURING HEMODIALYSIS
MA Boivin, SI Battah, EA Dominic, K Kalantar-Zadeh, A Ferrando, AH Tzamaloukas, R Dwivedi, TA Ma, P Moseley, DS Raj |
European Journal of Clinical Investigation | 2010 |
Management of Acute Kidney Problems
A Jörres, C Ronco, JA Kellum |
2009 | |
Modern Nutrition
K LaPoint, M McIntosh |
Handbook of Nutrition in the Aged, Fourth Edition | 2008 |
Management of hyperglycemia in patients with diabetes mellitus and chronic renal failure
C Sampanis |
Hippokratia | 2008 |
Cinacalcet: pharmacological and clinical aspects
P Messa, C Alfieri, B Brezzi |
Expert Opinion on Drug Metabolism & Toxicology | 2008 |
Pharmacological and clinical properties of calcimimetics: Calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism
N Nagano |
Pharmacology & Therapeutics | 2006 |
Derangement of glucose metabolism in hyperparathyroidism
M Procopio, G Borretta |
Journal of Endocrinological Investigation | 2003 |
Beneficial Effects of Calcimimetics on Progression of Renal Failure and Cardiovascular Risk Factors
H Ogata, E Ritz, G Odoni, K Amann, SR Orth |
Journal of the American Society of Nephrology : JASN | 2003 |
Intracellular free calcium in the neutrophils of maintenance haemodialysis patients
AM Koorts, MC Kruger, CD Potgieter, M Viljoen |
Clinical Physiology and Functional Imaging | 2002 |
Calcium in Internal Medicine
H Morii, Y Nishizawa, SG Massry |
2002 | |
Insulin secretion in uremia
SG Massry |
American Journal of Kidney Diseases | 2001 |
Lipid Metabolism and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Role of Factors Modulating Cytosolic Calcium
MF Gadallah, M El-Shahawy, G Andrews, C Torres-Rivera, D Hanna, M Blatt, M Ibrahim, A Morkos, M Abbassian, M Cooper |
Hemodialysis International | 2001 |
Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure
SG Rostand, TB Drueke |
Kidney International | 1999 |
Erythrocyte voltage-dependent calcium influx is reduced in hemodialyzed patients
L Soldati, D Adamo, S Zerbi, A Caumo, R Spaventa, G Bianchi, G Vezzoli |
Kidney International | 1999 |
Distribution of the Parathyroid Hormone 2 Receptor in Rat: Immunolocalization Reveals Expression by Several Endocrine Cells*
TB Usdin, J Hilton, T Vertesi, G Harta, G Segre, E Mezey |
Endocrinology | 1999 |
Elevated Myocardial Cytosolic Calcium Impairs Insulin-Like Growth Factor-1-Stimulated Protein Synthesis in Chronic Renal Failure
DA Qing, HU Ding, J Vadgama, YY Wu, JD Kopple |
Journal of the American Society of Nephrology : JASN | 1999 |
Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease
D Fliser, G Pacini, R Engelleiter, A Kautzky-Willer, R Prager, E Franek, E Ritz |
Kidney International | 1998 |
Critical Care Nephrology
C Ronco, R Bellomo |
1998 | |
Effects of excess PTH on nonclassical target organs
S Bro, K Olgaard |
American Journal of Kidney Diseases | 1997 |
Dysregulation of melatonin metabolism in chronic renal insufficiency: Role of erythropoietin-deficiency anemia
ND Vaziri, F Oveisi, GA Reyes, XJ Jhou |
Kidney International | 1996 |
Membrane protein damage and methylation reactions in chronic renal failure
AF Perna, D Ingrosso, P Galletti, V Zappia, NG de Santo |
Kidney International | 1996 |
Benefits of Calcitriol Therapy and Serum Phosphorus Control in Dogs and Cats with Chronic Renal Failure
LA Nagode, DJ Chew, M Podell |
Veterinary Clinics of North America Small Animal Practice | 1996 |
Impaired agonist-induced calcium signaling in hepatocytes from chronic renal failure rats
SG Massry, M Klin, Z Ni, J Tian, L Kedes, M Smogorzewski |
Kidney International | 1995 |
Middle Molecules: Toxicity and Removal by Hemodialysis and Related Strategies
R Vanholder, R Smet, P Vogeleere, S Ringoir |
Artificial Organs | 1995 |
Excess PTH in CRF induces pulmonary calcification, pulmonary hypertension and right ventricular hypertrophy
M Akmal, RR Barndt, AN Ansari, JG Mohler, SG Massry |
Kidney International | 1995 |
Verapamil reverses abnormal [Ca2+]i and carbohydrate metabolism of PMNL of dialysis patients
WH Hörl, M Haag-Weber, B Mai, SG Massry |
Kidney International | 1995 |
Elevated cytosolic calcium of adipocytes in chronic renal failure
Z Ni, M Smogorzewski, SG Massry |
Kidney International | 1995 |
Altered cytosolic calcium homeostasis in rat cardiac myocytes in CRF
YB Zhang, M Smogorzewski, Z Ni, SG Massry |
Kidney International | 1994 |
Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine
AF Pema, D Ingrosso, V Zappia, P Galletti, G Capasso, NG de Santo |
Journal of Clinical Investigation | 1993 |
Treatment and prevention of hyperkalemia in end-stage renal disease
M Allon |
Kidney International | 1993 |
Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia
M Allon, A Takeshian, N Shanklin |
Kidney International | 1993 |
Chronic Renal Failure is a State of Cellular Calcium Toxicity
SG Massry, GZ Fadda |
American Journal of Kidney Diseases | 1993 |
Verapamil Prevents Chronic Renal Failure-Induced Abnormalities in Lipid Metabolism
M Akmal, S Perkins, SE Kasim, HY Oh, M Smogorzewski, SG Massry |
American Journal of Kidney Diseases | 1993 |
Decreased O2 consumption by PMNL from humans and rats with CRF: Role of secondary hyperparathyroidism
M Kiersztejn, M Smogorzewski, P Thanakitcharu, GZ Fadda, SG Massry |
Kidney International | 1992 |
Cardiac Dysfunction in Chronic Uremia
PS Parfrey, JD Harnett |
1992 | |
Impaired insulin secretion of aging: Role of renal failure and hyperparathyroidism
SG Massry, GZ Fadda, XJ Zhou, P Chandrasoma, L Cheng, CR Filburn |
Kidney International | 1991 |
Inhibition of immunoglobulin production by parathyroid hormone. Implications in chronic renal failure
Z Gaciong, JM Alexiewicz, M Linker-Israeli, IA Shulman, TO Pitts, SG Massry |
Kidney International | 1991 |
Impaired potassium-induced insulin secretion in chronic renal failure
GZ Fadda, P Thanakitcharu, R Comunale, LG Lipson, SG Massry |
Kidney International | 1991 |
Impaired in vivo antibody production in CRF rats: Role of secondary hyperparathyroidism
Z Gaciong, JM Alexiewicz, SG Massry |
Kidney International | 1991 |
Replacement of Renal Function by Dialysis
W Drukker, FM Parsons, JF Maher |
1979 |